DK488078A - Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse - Google Patents

Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse

Info

Publication number
DK488078A
DK488078A DK488078A DK488078A DK488078A DK 488078 A DK488078 A DK 488078A DK 488078 A DK488078 A DK 488078A DK 488078 A DK488078 A DK 488078A DK 488078 A DK488078 A DK 488078A
Authority
DK
Denmark
Prior art keywords
preparation
quinazoline derivatives
derivatives procedure
procedure
quinazoline
Prior art date
Application number
DK488078A
Other languages
English (en)
Inventor
S F Campell
J C Danilewicz
A L Ham
J K Stubbs
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK488078A publication Critical patent/DK488078A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
DK488078A 1977-11-03 1978-11-01 Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse DK488078A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4566977 1977-11-03

Publications (1)

Publication Number Publication Date
DK488078A true DK488078A (da) 1979-05-04

Family

ID=10438111

Family Applications (1)

Application Number Title Priority Date Filing Date
DK488078A DK488078A (da) 1977-11-03 1978-11-01 Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse

Country Status (24)

Country Link
US (1) US4188391A (da)
JP (1) JPS5498786A (da)
AR (2) AR221851A1 (da)
AT (1) AT366043B (da)
AU (1) AU506317B2 (da)
BE (1) BE871769A (da)
CA (1) CA1086735A (da)
CH (1) CH637130A5 (da)
DE (1) DE2847622A1 (da)
DK (1) DK488078A (da)
ES (2) ES474763A1 (da)
FI (1) FI63934C (da)
FR (1) FR2407926A1 (da)
HK (1) HK94184A (da)
IE (1) IE47996B1 (da)
IL (1) IL55845A (da)
IT (1) IT1101287B (da)
KE (1) KE3351A (da)
LU (1) LU80461A1 (da)
MY (1) MY8500284A (da)
NL (1) NL174144C (da)
PH (1) PH14693A (da)
PT (1) PT68733A (da)
SE (1) SE7811323L (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
EP0669324A4 (en) * 1993-09-10 1996-04-03 Eisai Co Ltd CHINAZOLIN DERIVATIVES.
US6518423B1 (en) 1996-08-09 2003-02-11 Eisai Co., Ltd. Benzopiperidine derivatives
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
WO2008045673A2 (en) * 2006-10-06 2008-04-17 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2020190912A1 (en) 2019-03-19 2020-09-24 Stingray Therapeutics, Inc. Quinoline and quinazoline compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1199768A (en) * 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
US3812127A (en) * 1966-10-31 1974-05-21 Pfizer 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
AU4127778A (en) 1979-05-17
CA1086735A (en) 1980-09-30
MY8500284A (en) 1985-12-31
AR221851A1 (es) 1981-03-31
HK94184A (en) 1984-12-07
JPS5498786A (en) 1979-08-03
KE3351A (en) 1983-12-16
NL7810865A (nl) 1979-05-07
DE2847622A1 (de) 1979-05-31
FI63934C (fi) 1983-09-12
PH14693A (en) 1981-11-10
PT68733A (en) 1978-12-01
IL55845A0 (en) 1979-01-31
NL174144B (nl) 1983-12-01
IT7829368A0 (it) 1978-11-02
SE7811323L (sv) 1979-05-04
CH637130A5 (de) 1983-07-15
BE871769A (fr) 1979-05-03
US4188391A (en) 1980-02-12
FI783325A (fi) 1979-05-04
ES480053A1 (es) 1980-07-16
IL55845A (en) 1982-07-30
AT366043B (de) 1982-03-10
JPS566428B2 (da) 1981-02-10
FR2407926A1 (fr) 1979-06-01
ATA783878A (de) 1981-07-15
FI63934B (fi) 1983-05-31
NL174144C (nl) 1984-05-01
FR2407926B1 (da) 1982-11-12
IT1101287B (it) 1985-09-28
AR221251A1 (es) 1981-01-15
LU80461A1 (fr) 1980-05-07
ES474763A1 (es) 1980-12-16
AU506317B2 (en) 1979-12-20
IE47996B1 (en) 1984-08-22

Similar Documents

Publication Publication Date Title
DK488078A (da) Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK222382A (da) Benzezepinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK93880A (da) Polyolderivater samt deres fremstilling og anvendelse
DK47476A (da) Benzoylureido-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK47376A (da) Benzoylureido-nitro-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse
DK291180A (da) Indolizinderivater samt fremgangsmaade til fremstilling deraf
DK487978A (da) Phthalaziner fremgangsmaade til deres fremstilling samt deres anvendelse
DK95678A (da) Tetrahydrofuranetherderivater fremgangsmaade til fremtilling deraf samt deres anvendelse som herbicider
DK203378A (da) Azolylether-derivater fremgangsmaade til deres fremstilling samt deres anvendelse som fungicider
DK37278A (da) Meta-sulfonamido-benzamid-derivater samt fremgangsmaade til fremstilling deraf
DK410878A (da) Paa siliciumdioxid baserede skumbekaempende kompostitoner med forbedret stabilitet fremgangsmaade til deres fremstilling samt deres anvendelse
DK147378A (da) Imidazodiazepinderivater samt fremgangsmaade til fremstilling deraf
DK46478A (da) N-substituerede halogenacetanilider fremgangsmaade til deres fremstilling samt deres anvendelse som herbicider
DK212778A (da) Sesquiterpen-derivater og salte deraf samt fremgangsmaade til deres fremstilling
DK59177A (da) Anellerede pyrimidinderivater samt deres fremstilling og anvendelse
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
DK537677A (da) Propionsyrederivater samt fremgangsmaade til deres fremstilling
DK474678A (da) Halogenvinyl-gamma-butyrolactoner samt deres fremstilling og anvendelse
DK319578A (da) Angiotensinpeptider samt deres fr&mstilling
DK140680A (da) Dispergeringsmidler fremgangsmaade til deres fremstilling samt deres anvendelse
DK391678A (da) Nitrogen-heterocycliske forbindelser fremgangsmaade til deres fremstilling samt deres anvendelse
DK92880A (da) 6-beta-substituerede penicillansyrer fremgangsmaade til deres fremstilling samt deres anvendelse
DK318278A (da) Beta-lactamforbindelser samt deres femstilling og anvendelse
DK564778A (da) Azolylalkyl-pyridinyl-ethere fremgangsmaader til deres fremstilling samt deres anvendelse som fungicider

Legal Events

Date Code Title Description
ATS Application withdrawn